196 related articles for article (PubMed ID: 12542835)
1. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Kumamoto H; Yamauchi K; Yoshida M; Ooya K
J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
[TBL] [Abstract][Full Text] [Related]
3. Interplay Between MMP-9 and TIMP-2 Regulates Ameloblastoma Behavior and Tooth Morphogenesis.
Nunia K; Urs AB; Kumar P
Appl Immunohistochem Mol Morphol; 2016; 24(5):364-72. PubMed ID: 26067137
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
[TBL] [Abstract][Full Text] [Related]
5. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
Kumamoto H; Takahashi N; Ooya K
J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
[TBL] [Abstract][Full Text] [Related]
7. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
[TBL] [Abstract][Full Text] [Related]
9. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of matrix metalloproteinases in ameloblastomas and pericoronal follicles.
Dutra KL; Cordeiro MM; Vieira DS; Rivero ER
J Oral Pathol Med; 2016 Sep; 45(8):586-90. PubMed ID: 26694521
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors.
Kumamoto H; Ooya K
Oral Dis; 2007 Sep; 13(5):461-7. PubMed ID: 17714348
[TBL] [Abstract][Full Text] [Related]
13. Detection of cell cycle-related factors in ameloblastomas.
Kumamoto H; Kimi K; Ooya K
J Oral Pathol Med; 2001 May; 30(5):309-15. PubMed ID: 11334468
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
[TBL] [Abstract][Full Text] [Related]
17. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
Kumamoto H; Ohki K
J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
Kumamoto H; Yoshida M; Ooya K
J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
[TBL] [Abstract][Full Text] [Related]
20. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
